USP53 Activators are a diverse set of chemical compounds that indirectly enhance the functional activity of USP53 through various signaling pathways. Forskolin, by augmenting cAMP levels, facilitates PKA activation that can lead to phosphorylation events enhancing USP53's role in deubiquitination processes. Epigallocatechin gallate, as a kinase inhibitor, simplifies the cellular signaling environment for USP53, potentially allowing for more efficient deubiquitination activity. Ionomycin, through its action as a calcium ionophore, increases intracellular calcium that activates calcium-dependent enzymes, possibly affecting the phosphorylation state of USP53 and thus its activity. PMA and Sphingosine-1-phosphate, targeting PKC and sphingolipid signaling pathways respectively, create a cellular context that may facilitate the phosphorylation of USP53 or its associated proteins, leading to enhanced deubiquitination function.
Furthermore, the activity of USP53 is indirectly influenced by compounds such as Calyculin A and Okadaic acid, which inhibit protein phosphatases, thereby potentially increasing the phosphorylation of proteins that regulate USP53, enhancing its functional role. PI3K inhibitorslike LY294002 and Wortmannin may indirectly promote USP53 activity by modifying signaling cascades that impinge upon USP53 regulatory mechanisms. The MEK inhibitor U0126 and the p38 MAP kinase inhibitor SB203580 may also tilt the balance of cellular signaling in favor of enhancing USP53 activity by decreasing competing phosphorylation events. Lastly, ZM-447439, an Aurora kinase inhibitor, could indirectly foster USP53's deubiquitination activity by influencing the phosphorylation dynamics of USP53 or the proteins it interacts with. Collectively, these activators, through their targeted biochemical effects, underscore the intricate network of signaling pathways that converge on the regulation of USP53, thus amplifying its essential role in cellular deubiquitination processes without directly increasing its expression or activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylate cyclase, leading to an increase in cAMP levels, which enhances PKA activity. PKA can phosphorylate USP53, thereby potentially enhancing its deubiquitination activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
This polyphenol inhibits several kinases, potentially decreasing competitive signaling pathways and indirectly enhancing USP53 activity by allowing it to operate more efficiently in protein deubiquitination. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin acts as a calcium ionophore, increasing intracellular calcium levels and activating calcium-dependent phosphatases that may indirectly enhance USP53 activity by modulating its phosphorylation state. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC), which can influence signaling pathways that may phosphorylate USP53 or its substrates, potentially enhancing USP53's deubiquitination process. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
Sphingosine-1-phosphate modulates sphingolipid signaling pathways, which can lead to the activation of kinases that phosphorylate proteins interacting with USP53, thereby potentially enhancing its activity. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000B sc-24000C | 10 µg 100 µg 500 µg 1 mg | $160.00 $750.00 $1400.00 $3000.00 | 59 | |
As an inhibitor of certain protein phosphatases, Calyculin A may indirectly increase the phosphorylation of proteins that regulate USP53 activity, thus potentially enhancing its functional role. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Okadaic acid, a potent inhibitor of protein phosphatases 1 and 2A, may indirectly enhance USP53 activity by increasing phosphorylation levels of regulatory proteins that interact with USP53. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor, which may lead to altered signaling cascades that indirectly enhance the activity of USP53 by affecting proteins that modulate its activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is another PI3K inhibitor, which could enhance USP53 activity by similar mechanisms as LY294002, through altering signaling pathways that affect USP53 regulation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 inhibits p38 MAP kinase, potentially leading to enhanced USP53 activity by altering the phosphorylation state of proteins that interact with or regulate USP53. | ||||||